Dave Kille

Dave Kille has a diverse work experience spanning multiple companies and industries. Dave began their career as a Senior Auditor at Ernst & Young in 1999 and worked there until 2002. Following their time at Ernst & Young, Dave joined Windtree Therapeutics, Inc. (formerly Discovery Laboratories, Inc.) in 2002 as a Manager in Financial Accounting & Reporting. Dave worked in various roles within the company until 2010, including Manager of Financial Reporting & Consolidations. In 2010, Dave joined Globus Medical, Inc. as a Manager in Financial Reporting & Consolidations. Dave then moved on to Windtree Therapeutics, Inc. (formerly Discovery Laboratories, Inc.) again in 2012, this time as a Senior Director in Finance & Controller. In 2015, Dave joined Safeguard Scientifics as a Corporate Controller, and in 2018, they joined Arbutus Biopharma Corporation as a Corporate Controller. Dave was later promoted to Senior Vice President, Controller at Arbutus Biopharma Corporation in May 2021.

Dave Kille attended Penn State University from 1995 to 1999, where they earned a Bachelor of Science degree in Accounting. Dave also obtained a certification as a Certified Public Accountant in Pennsylvania, although it is currently inactive. The year and month of obtaining this certification are not specified.